메뉴 건너뛰기




Volumn 206, Issue 6, 2012, Pages 811-820

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without as03 adjuvant system in healthy adults and older persons

(15)  Jackson, Lisa A a   Chen, Wilbur H c   Stapleton, Jack T e   Dekker, Cornelia L f   Wald, Anna b   Brady, Rebecca C g   Edupuganti, Srilatha h   Winokur, Patricia e   Mulligan, Mark J h   Keyserling, Harry L h   Kotloff, Karen L c   Rouphael, Nadine h   Noah, Diana L i   Hill, Heather d   Wolff, Mark C d  


Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; VIRUS RNA;

EID: 84865780933     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis427     Document Type: Article
Times cited : (34)

References (34)
  • 1
    • 77953142652 scopus 로고    scopus 로고
    • Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: A phase ii, randomized, open, controlled study
    • Diez-Domingo J, Garces-Sanchez M, Baldo JM, et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J 2010; 29:e35-46.
    • (2010) Pediatr Infect Dis J , vol.29
    • Diez-Domingo, J.1    Garces-Sanchez, M.2    Baldo, J.M.3
  • 2
    • 77951883155 scopus 로고    scopus 로고
    • Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: A randomized controlled phase 1/2 trial in adults
    • Langley JM, Frenette L, Ferguson L, et al. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J Infect Dis 2010; 201:1644-53.
    • (2010) J Infect Dis , vol.201 , pp. 1644-1653
    • Langley, J.M.1    Frenette, L.2    Ferguson, L.3
  • 3
    • 34547837401 scopus 로고    scopus 로고
    • Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial
    • Leroux-Roels I, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007; 370:580-9.
    • (2007) Lancet , vol.370 , pp. 580-589
    • Leroux-Roels, I.1    Borkowski, A.2    Vanwolleghem, T.3
  • 4
    • 70349861815 scopus 로고    scopus 로고
    • Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
    • Chu DW, Hwang SJ, Lim FS, et al. Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Vaccine 2009; 27:7428-35.
    • (2009) Vaccine , vol.27 , pp. 7428-7435
    • Chu, D.W.1    Hwang, S.J.2    Lim, F.S.3
  • 5
    • 70350025172 scopus 로고    scopus 로고
    • Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
    • Schwarz TF, Horacek T, Knuf M, et al. Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 2009; 27:6284-90.
    • (2009) Vaccine , vol.27 , pp. 6284-6290
    • Schwarz, T.F.1    Horacek, T.2    Knuf, M.3
  • 6
    • 79953301948 scopus 로고    scopus 로고
    • Immunogenicity Profile of a 3.75-{micro}g hemagglutinin pandemic rH5N1 split virion AS03A-Adjuvanted vaccine in elderly persons: A randomized trial
    • Heijmans S, De Meulemeester M, Reynders P, et al. Immunogenicity Profile of a 3.75-{micro}g hemagglutinin pandemic rH5N1 split virion AS03A-Adjuvanted vaccine in elderly persons: a randomized trial. J Infect Dis 2011; 203:1054-62.
    • (2011) J Infect Dis , vol.203 , pp. 1054-1062
    • Heijmans, S.1    De Meulemeester, M.2    Reynders, P.3
  • 8
    • 77953727656 scopus 로고    scopus 로고
    • Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: Open label, randomised, parallel group, multicentre study
    • Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010; 340:c2649.
    • (2010) BMJ , vol.340
    • Waddington, C.S.1    Walker, W.T.2    Oeser, C.3
  • 9
    • 77955560311 scopus 로고    scopus 로고
    • Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
    • Carmona A, Omenaca F, Tejedor JC, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine 2010; 28:5837-44.
    • (2010) Vaccine , vol.28 , pp. 5837-5844
    • Carmona, A.1    Omenaca, F.2    Tejedor, J.C.3
  • 10
    • 79957824323 scopus 로고    scopus 로고
    • Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
    • Garcia-Sicilia J, Gillard P, Carmona A, et al. Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. Vaccine 2011; 29:4353-61.
    • (2011) Vaccine , vol.29 , pp. 4353-4361
    • Garcia-Sicilia, J.1    Gillard, P.2    Carmona, A.3
  • 11
    • 75249101993 scopus 로고    scopus 로고
    • Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomised trial
    • Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03(A)-adjuvant: Preliminary report of an observer-blind, randomised trial. Vaccine 2010; 28:1740-5.
    • (2010) Vaccine , vol.28 , pp. 1740-1745
    • Roman, F.1    Vaman, T.2    Gerlach, B.3    Markendorf, A.4    Gillard, P.5    Devaster, J.M.6
  • 13
    • 78751704276 scopus 로고    scopus 로고
    • Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: A randomised, multicentre, agestratified, head-to-head trial
    • Nicholson KG, Abrams KR, Batham S, et al. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, agestratified, head-to-head trial. Lancet Infect Dis 2011; 11:91-101.
    • (2011) Lancet Infect Dis , vol.11 , pp. 91-101
    • Nicholson, K.G.1    Abrams, K.R.2    Batham, S.3
  • 14
    • 77955937857 scopus 로고    scopus 로고
    • AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age
    • Roman F, Vaman T, Kafeja F, Hanon E, Van Damme P. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age. Clin Infect Dis 2010; 51:668-77.
    • (2010) Clin Infect Dis , vol.51 , pp. 668-677
    • Roman, F.1    Vaman, T.2    Kafeja, F.3    Hanon, E.4    Van Damme, P.5
  • 15
    • 78649690134 scopus 로고    scopus 로고
    • An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
    • Madhun AS, Akselsen PE, Sjursen H, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010; 29:266-73.
    • (2010) Vaccine , vol.29 , pp. 266-273
    • Madhun, A.S.1    Akselsen, P.E.2    Sjursen, H.3
  • 16
    • 85083607961 scopus 로고    scopus 로고
    • Health Canada Accessed 15 July 2010
    • Health Canada. Notice of Decision for AREPANRIX™ H1N1. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/phase1-decision/drugmed/ nd-ad-2009-arepanrix-h1n1-132070-eng.php. Accessed 15 July 2010.
    • Notice of Decision for AREPANRIX™ H1N1
  • 17
    • 80052228226 scopus 로고    scopus 로고
    • Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women
    • Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 6:854-63.
    • (2011) J Infect Dis , vol.6 , pp. 854-863
    • Jackson, L.A.1    Patel, S.M.2    Swamy, G.K.3
  • 18
    • 73049100357 scopus 로고    scopus 로고
    • Immune response after a single vaccination against 2009 influenza A H1N1 in USA: A preliminary report of two randomised controlled phase 2 trials
    • Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375:41-8.
    • (2010) Lancet , vol.375 , pp. 41-48
    • Plennevaux, E.1    Sheldon, E.2    Blatter, M.3    Reeves-Hoche, M.K.4    Denis, M.5
  • 19
    • 72949104686 scopus 로고    scopus 로고
    • Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, doubleblind, randomised, placebo-controlled trial
    • Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, doubleblind, randomised, placebo-controlled trial. Lancet 2010; 375:56-66.
    • (2010) Lancet , vol.375 , pp. 56-66
    • Liang, X.F.1    Wang, H.Q.2    Wang, J.Z.3
  • 20
    • 72449197465 scopus 로고    scopus 로고
    • A novel influenza A (H1N1) vaccine in various age groups
    • Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414-23.
    • (2009) N Engl J Med , vol.361 , pp. 2414-2423
    • Zhu, F.C.1    Wang, H.2    Fang, H.H.3
  • 21
    • 77958099793 scopus 로고    scopus 로고
    • A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults
    • Talaat KR, Greenberg ME, Lai MH, et al. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis 2010; 202:1327-37.
    • (2010) J Infect Dis , vol.202 , pp. 1327-1337
    • Talaat, K.R.1    Greenberg, M.E.2    Lai, M.H.3
  • 22
    • 72449172862 scopus 로고    scopus 로고
    • Response to a monovalent 2009 influenza A (H1N1) vaccine
    • Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-13.
    • (2009) N Engl J Med , vol.361 , pp. 2405-2413
    • Greenberg, M.E.1    Lai, M.H.2    Hartel, G.F.3
  • 23
    • 80053628262 scopus 로고    scopus 로고
    • Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and nonadjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
    • Andrews NJ, Walker WT, Finn A, et al. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and nonadjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine 2011; 29:7913-9.
    • (2011) Vaccine , vol.29 , pp. 7913-7919
    • Andrews, N.J.1    Walker, W.T.2    Finn, A.3
  • 24
    • 79954610458 scopus 로고    scopus 로고
    • Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: Lowered antibody response by prior seasonal vaccination
    • Ohfuji S, Fukushima W, Deguchi M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011; 203:1301-8.
    • (2011) J Infect Dis , vol.203 , pp. 1301-1308
    • Ohfuji, S.1    Fukushima, W.2    Deguchi, M.3
  • 25
    • 80755161302 scopus 로고    scopus 로고
    • Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: A randomized controlled trial
    • Uno S, Kimachi K, Kei J, et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial. Microbiol Immunol 2011; 55:783-9.
    • (2011) Microbiol Immunol , vol.55 , pp. 783-789
    • Uno, S.1    Kimachi, K.2    Kei, J.3
  • 26
    • 56049127353 scopus 로고    scopus 로고
    • Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
    • Nolan T, Richmond PC, Formica NT, et al. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 2008; 26: 6383-91.
    • (2008) Vaccine , vol.26 , pp. 6383-6391
    • Nolan, T.1    Richmond, P.C.2    Formica, N.T.3
  • 27
    • 71249164116 scopus 로고    scopus 로고
    • Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
    • Leroux-Roels I, Roman F, Forgus S, et al. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine 2010; 28:849-57.
    • (2010) Vaccine , vol.28 , pp. 849-857
    • Leroux-Roels, I.1    Roman, F.2    Forgus, S.3
  • 28
    • 77951832163 scopus 로고    scopus 로고
    • Immunogenicity and safety of intradermal influenza vaccination in healthy older adults
    • Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010; 50:1331-8.
    • (2010) Clin Infect Dis , vol.50 , pp. 1331-1338
    • Chi, R.C.1    Rock, M.T.2    Neuzil, K.M.3
  • 29
    • 0035860619 scopus 로고    scopus 로고
    • Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors
    • Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001; 19:4703-9.
    • (2001) Vaccine , vol.19 , pp. 4703-4709
    • Jackson, L.A.1    Austin, G.2    Chen, R.T.3
  • 30
    • 58149100516 scopus 로고    scopus 로고
    • Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): Age, dose, and sex effects on immune responses
    • Engler RJ, Nelson MR, Klote MM, et al. Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168:2405-14.
    • (2008) Arch Intern Med , vol.168 , pp. 2405-2414
    • Engler, R.J.1    Nelson, M.R.2    Klote, M.M.3
  • 31
    • 34548241788 scopus 로고    scopus 로고
    • Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
    • Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007; 25:6755-63.
    • (2007) Vaccine , vol.25 , pp. 6755-6763
    • Belshe, R.B.1    Newman, F.K.2    Wilkins, K.3
  • 32
    • 34250800842 scopus 로고    scopus 로고
    • A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
    • Atmar RL, Keitel WA, Cate TR, Munoz FM, Ruben F, Couch RB. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine 2007; 25:5367-73.
    • (2007) Vaccine , vol.25 , pp. 5367-5373
    • Atmar, R.L.1    Keitel, W.A.2    Cate, T.R.3    Munoz, F.M.4    Ruben, F.5    Couch, R.B.6
  • 33
    • 0037081382 scopus 로고    scopus 로고
    • Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
    • Treanor J, Keitel W, Belshe R, et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002; 20:1099-105.
    • (2002) Vaccine , vol.20 , pp. 1099-1105
    • Treanor, J.1    Keitel, W.2    Belshe, R.3
  • 34
    • 79957453401 scopus 로고    scopus 로고
    • Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: A phase III, placebo-controlled, randomized study
    • Langley JM, Risi G, Caldwell M, et al. Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: a Phase III, Placebo-Controlled, Randomized Study. J Infect Dis 2011; 203:1729-38.
    • (2011) J Infect Dis , vol.203 , pp. 1729-1738
    • Langley, J.M.1    Risi, G.2    Caldwell, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.